Sophono Named Colorado Company to Watch Finalist
CID4 Seeks Graduate Interns for 2011/2012 Academic Calendar
UPDATE | The Application Deadline Has Been Extended to COB Monday 7 November
CID4 is now seeking graduate student interns for the remaining 2011/2012 academic calendar.
Graduate interns will have an opportunity to be involved in many aspects of business development, implementation and program activities while providing key support to management and staff. Additionally, all CID4 interns share responsibilities for administrative tasks that keep the office running smoothly and ensure top quality program support. In a busy professional setting, candidates must be good team players, know how to prioritize tasks and manage their time well. Expect to allocate a minimum of ten-hours per week to your internship.
Under the supervision of senior management, the CID4 graduate intern(s) will assist in the construction of a competitive intelligence virtual library that may ultimately function as an important shared resource for the entire Colorado bioscience ecosystem. In addition, assistance with research and due diligence, and other development projects are required.
To receive the application packet forward your resume to arubenstein@cid4.com.
Application deadline for 2011/2012 academic calendar appointments is October 31.
Download job description here.
All Portfolio Companies Accepted to Present at the 2011 Rocky Mountain Life Science Investor and Partnering Conference
All four CID4 portfolio companies, Sophono, PeptiVir, VetDC and Flashback Technologies, have been accepted to present and participate in partnering discussions at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC).
Organized by the Colorado BioScience Association, the RMLIPC is the Rocky Mountain region’s premiere investor and partnering conference, attracting venture capital funds, corporate venture funds and business development leaders from the largest global biopharmaceutical and medical device companies – all convening in Denver, CO September 21-23, 2011. The conference incorporates a robust and competitive company selection process that is filtered by a national committee of life science investors and business development executives. The selection committee recently released names of the thirty companies hand-picked to attend and present over the course of the three-day conference.
CID4’s mission to advance the Colorado bioscience ecosystem through company creation and job growth is only partially fulfilled through project investment, it is the active management role that yields tangible progressive milestone-driven value, such as architecting early-stage company roadmaps and assisting in the raising of follow-on capital. Positioning a portfolio company in front of institutional capital and potential industry partners is a critical function played by CID4 management. Having Sophono, PeptiVir, VetDC and Flashback Technologies participate speaks to the quality of technologies emerging from Colorado and validates the CID4 project selection process which is driven by the industry professionals who generously volunteer their time and expertise as members of CID4’s Technical and Business Advisory Committee.”“Our Association spearheads the investor and partnering conference every other year for the region. This is our second event, and we have been absolutely thrilled at the response from both companies applying to present and investors desiring to attend,” said Holli Riebel, President and CEO of the Colorado BioScience Association. “The selection of four CID4 Project companies to present at this year’s conference is a reflection of CID4’s role as more than just a source of investment capital, but also an active participant in the management of its Project companies.” Comments
August 5th: Submission Date for New Project Consideration
CID4 is seeking its fifth project. A review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. Material may be submitted HERE.
CID4 recently launched a new website where business plans of all shapes and sizes are submitted online on a rolling basis. The new CID4 Innovation Database is proving to be a powerful tool, enabling industry partners and investors from all over world to reach into the technology-rich Colorado life science ecosystem. Providing an efficient, single point of entry, the database has been warmly received by both commercial partners and institutional investors and is being validated as an effective tool for catalyzing significant opportunities for Colorado entrepreneurs. Companies or technology business plans that had been uploaded to the CID4 Innovation Database were presented at the intense partnering and investor conferences C21 BioVentures in Napa, CA in May and BIO 2011 in Washington, D.C. in June.
Those companies and technologies who submit their content by the August 5th cut-off will be considered for review by management and the Technical and Business Advisory Committee (TBAC). For more details about the project selection process visit HERE. Rolling submissions received following the August 5th cut-off will be considered in the next project evaluation session, date announcement forthcoming.
CID4 has committed $1.25 million to four projects, which have created 22 direct jobs and raised an additional $1.3 million of investment capital. CID4 is delivering on its mission of Economic Development through Innovation Advancement.
Comments